Kesimpta Pregnancy and Infant Safety Study Using Real World Data

NCT06156683 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: Multiple sclerosis disease modifying drug

Sponsor

Novartis Pharmaceuticals